I was sad to read this but not terribly surprised. Merck's new business model is to pick the drugs they want and spit out any future research. How far they have fallen. I'm sorry you got purchased by them.
For some of you at Cubist this might feel a little like deja vu. When Cubist bought Trius, one of the first things they did was give notice to R&D. What goes around comes around.
